학술논문

Diagnostic and clinical value of [18F]FDG PET/CT in the follow-up regimen in IIA--IIID stage cutaneous malignant melanoma after first regional recurrence.
Document Type
Article
Source
Nuclear Medicine Review; 2023, Vol. 26, p20-28, 9p
Subject
DISEASE progression
PUBLIC health surveillance
PREDICTIVE tests
CANCER relapse
RETROSPECTIVE studies
TUMOR classification
CUTANEOUS malignant melanoma
RADIOPHARMACEUTICALS
DESCRIPTIVE statistics
DEOXY sugars
COMPUTED tomography
SENSITIVITY & specificity (Statistics)
EMISSION-computed tomography
Language
ISSN
15069680
Abstract
Copyright of Nuclear Medicine Review is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)